Elevai Labs Inc. (ELAB)
After hours:
| Previous Close | 0.0159 |
| Open | 0.0145 |
| Bid | 0.0100 x 900 |
| Ask | 0.0380 x 158500 |
| Day's Range | 0.0125 - 0.0148 |
| 52 Week Range | 0.0125 - 4.2000 |
| Volume | |
| Avg. Volume | 111,847,823 |
| Market Cap | 6.471M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4400 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireElevai Labs Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance
NEWPORT BEACH, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Elevai Labs Inc. (NASDAQ: ELAB) (Elevai" or the "Company") announced today it will implement a 1-for-200 reverse stock split (“Reverse Stock Split”) of its common stock, which will be effective at midnight on November 27, 2024. This initiative aligns with the Company’s efforts to meet Nasdaq's minimum bid price requirement of $1.00 per share under Listing Rule 5550(a)(2). Key Details of the Reverse Stock Split:- Conversion Ratio: Every 200
- GlobeNewswire
Elevai Labs Inc. Announces Withdrawal of Offer to Exchange and Plans to Reassess
NEWPORT BEACH, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Elevai Labs, Inc. (NASDAQ: ELAB) (“Elevai” or the “Company”), a leader in medical aesthetics, announced today that it is has withdrawn the previously announced offer (the “Offer”) to holders of the Company’s outstanding Common Stock (the “Common Stock”), to exchange up to 15,000,000 shares of Common Stock for up to 15,000,000 shares of the Company’s newly issued Series B Preferred Stock (“Series B Preferred Stock”), as a result of notice f
